Biomea Fusion Inc.
Clinical trials sponsored by Biomea Fusion Inc., explained in plain language.
-
New diabetes pill aims to help when current meds fall short
Disease control Recruiting nowThis study tests a new drug called icovamenib in 60 adults with type 2 diabetes whose blood sugar is not well controlled despite taking other diabetes medications. Participants will take either icovamenib or a placebo daily for 12 weeks to see if it improves blood sugar levels. T…
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New diabetes pill shows promise for patients stuck on ozempic
Disease control Recruiting nowThis study tests a new daily pill, icovamenib, for people with type 2 diabetes whose blood sugar is still too high despite taking Ozempic. About 60 adults will receive either the drug or a placebo for 12 weeks to see if it safely improves blood sugar control. The goal is to offer…
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC